381 results on '"Danova, M."'
Search Results
2. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
3. Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues
4. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation
5. Cord blood in vitro expanded CD41+ cells: identification of novel components of megakaryocytopoiesis
6. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects
7. 5-Fluorouracil plus interferon α-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: A multicentric randomized study
8. Adjuvant high-dose chemotherapy with autologous haematopoietic stem cell transplantation for breast cancer in Italy: 15-years results from the GITMO registry
9. Reduced number and function of peripheral dendritic cells in coeliac disease
10. Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor
11. PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues: A combined immunocytochemical and flow cytometric study
12. Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transplantation
13. New approaches for reduction of oral mucositis in patients undergoing high-dose chemotherapy with haematopoietic stem cell support
14. Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study
15. THE NUMBER AND FUNCTION OF BLOOD DENDRITIC CELLS IN PATIENTS WITH COLORECTAL CANCER CORRELATES WITH DISEASE STATUS: THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR
16. HET REGIMEN (TRASTUZUMAB, EPIRUBICIN ANDTAXOTERE) AS A FIRST LINE TREATMENT IN METASTATIC BREAST CANCER. A MULTICENTER PHASE II STUDY
17. HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC): GOOD PALLIATION WITH FOLFOX REGIMEN
18. RECOMBINANT HUMAN INTERLEUKIN-11 AFTER AUTOLOGOUS CIRCULATING PROGENITOR CELL TRANSPLANTATION IN BREAST CANCER
19. CIRCULATING PROGENITOR CELL (CPC) OXIDATIVE DNA DAMAGE, EVALUATED THROUGH ITS MARKER 8-HYDROX-2′- DEOXY - GUANOSINE (8-OHdG), CORRELATES WITH CPC APOPTOSIS AND A POOR OR COMPLICATED TRANSPLANTATION OUTCOME IN EARLY BREAST CANCER AND NON
20. DENDRITIC CELL DETECTION IN PERIPHERAL BLOOD AFTER PRIMING WITH DIFFERENT CD34+ MOBILIZING REGIMENS IN NORMAL DONORS AND BREAST CANCER PATIENTS
21. IMPACT OF TOPOTECAN ON THE IMMUNE SYSTEM OF STAGE IV EPITHELIAL OVARIAN CANCER PATIENTS
22. EVOLUTION OF THE MEDICAL TREATMENT OF ADVANCED RENAL CELL CARCINOMA AT A SINGLE INSTITUTION: THE EXPERIENCE OF THE IRCCS SAN MATTEO UNIVERSITY HOSPITAL
23. High-dose chemotherapy (HDT) with tandem autologous peripheral blood progenitor cells (PBPC) transplantation for patients with metastatic breast cancer (MBC).
24. Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol
25. Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle
26. Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial
27. Clinical and Translational Results of a Phase II Randomized Trial o Maintenance Sunitinib (MS) or Observation (O) n Metastatic Pancreatic Adenocarcinoma
28. Multisystemic disease with intracranial hypertension and autoimmune cytopenia in chronic active hepatitis
29. Refractory cytopenias: Clinical course according to bone marrow cytology and cellularity
30. Proliferation kinetics of bone marrow cells in congenital dyserythropoietic anemia type II
31. In vivo bromodeoxyuridine incorporation in human gastric cancer: A study on formalin-fixed and paraffin-embedded sections
32. Propidium iodide staining of cytoautoradiographic preparations for the simultaneous determination of DNA content and grain count
33. COMPLEXIFICATION METHODS OF INTERVAL FORECAST ESTIMATES IN THE PROBLEMS ON SHORT-TERM PREDICTION.
34. The metastatic potential of tumor cells can be revealed by 3D culture on a silicon optical microchip
35. Evaluation of the metastatic potential of human tumor cells by means of 3D culture on silicon microstructures
36. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer
37. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)
38. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009
39. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009
40. VEGF gene polymorphisms in the prediction of benefit from first-line folfiri plus bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients (pts)
41. The recovery of circulating endritc cells during anti-VEGF treatment is related to clinical outcome in advanced colorectal cancer patients
42. Immunological effects of the anti-vegf therapy: an additional mechanism of action in colorectal cancer patients?
43. T20 - Implementation of the International Myeloma Working Group reccomendations on renal impairment in multiple myeloma patients in routine clinical practice
44. Cord blood in vitro expanded CD41+ cells: Identification novel components of megakaryocytopoiesis
45. DOSE AND OUTCOME. THE HURDLE OF NEUTROPENIA
46. ORGANIZATION OF INFORMATION SUPPORT FOR BUSINESS PROCESSES AT AVIATION ENTERPRISES BY MEANS OF ONTOLOGICAL ENGINEERING.
47. Objective response to chemotherapy as a potential surrogate of survival in metastatic breast cancer patients.:Plus Commentary
48. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
49. Dose-dense vinorelbine and paclitaxel with granulocyte colonyDose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability
50. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.